InspireMD to Announce First Quarter 2025 Financial Results

Core Viewpoint - InspireMD, Inc. is set to release its first quarter 2025 financial results on May 9, 2025, and will host a conference call to discuss these results and recent highlights [1]. Company Overview - InspireMD, Inc. develops the CGuard™ Prime carotid stent system aimed at treating carotid artery disease (CAD) and preventing strokes [1]. - The company utilizes proprietary MicroNet technology to establish its products as the industry standard for carotid stenting, focusing on delivering excellent acute results and long-term, stroke-free outcomes [3]. - InspireMD's common stock is traded on Nasdaq under the ticker symbol NSPR [3]. Conference Call Details - The conference call will take place at 8:30 a.m. Eastern Time on May 9, 2025, and will be accessible via telephone and webcast [1][2]. - Domestic callers can dial 1-800-579-2543, while international callers can reach the call at 1-785-424-1789 [2]. - A replay of the webinar will be available shortly after the call and archived on InspireMD's website [2].